Comparative analysis of gene expression profiles of OPN signalling pathway in four kinds of liver diseases

Journal of Genetics

Volumn 95, Issue 3, 2016, Pages 741-750

  Wang, Gaiping ^a   Chen, Shasha ^a   Zhao, Congcong ^a   Li, Xiaofang ^a   Zhao, Weiming ^a   Yang, Jing ^a   Chang, Cuifang ^a   Xu, Cunshuan ^a  

^a HENAN NORMAL UNIVERSITY   (China)

Author keywords

acute hepatic failure; hepatic cancer; liver cirrhosis; nonalcoholic fatty liver disease; osteopontin signalling pathway

Indexed keywords

OSTEOPONTIN; SPP1 PROTEIN, RAT; TRANSCRIPTOME;

ACUTE LIVER FAILURE; ANIMAL; BIOLOGY; COMPARATIVE STUDY; DISEASE MODEL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; LIVER CIRRHOSIS; LIVER TUMOR; MALE; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANIMALS; COMPUTATIONAL BIOLOGY; DISEASE MODELS, ANIMAL; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME-WIDE ASSOCIATION STUDY; LIVER CIRRHOSIS; LIVER FAILURE, ACUTE; LIVER NEOPLASMS; MALE; METABOLIC NETWORKS AND PATHWAYS; NON-ALCOHOLIC FATTY LIVER DISEASE; OSTEOPONTIN; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; TRANSCRIPTOME;

EID: 84982791075     PISSN: 00221333     EISSN: 09737731     Source Type: Journal    
DOI: 10.1007/s12041-016-0673-7     Document Type: Review

References (37)

1. Behera R., Kumar V., Lohite K., Karnik S. and Kundu G. C. 2010 Activation of JAK2/STAT3 signaling by osteopontin promotes tumor growth in human breast cancer cells. Carcinogenesis 31, 192–200.
2. Chakraborty G., Jain S., Behera R., Ahmed M., Sharma P., Kumar V. et al. 2006 The multifaceted roles of osteopontin in cell signaling, tumor progression and angiogenesis. Curr. Mol. Med. 6, 819–830.
3. Chen L. Y., Yang B., Zhou L., Ren F., Duan Z. P. and Ma Y. J. 2015 Promotion of mitochondrial energy metabolism during hepatocyte apoptosis in a rat model of acute liver failure. Mol. Med. Rep. 12, 5035–5041.
4. Denhardt D. T., Giachelli C. M. and Rittling S. R. 2001 Role of osteopontin in cellular signaling and toxicant injury. Annu. Rev. Pharmacol. Toxicol. 41, 723–749.
5. Ganji S. H., Kashyap M. L. and Kamanna V. S. 2015 Niacin inhibits fat accumulation, oxidative stress, and inflammatory cytokine IL-8 in cultured hepatocytes: impact on non-alcoholic fatty liver disease. Metabolism 64, 982–990.
6. Guo G. B. and Xu C. S. 2008 Expression profiles of the organic acid metabolism-associated genes during rat liver regeneration. Amino Acids 34, 597–604.
7. Hosack D. A., Dennis Jr. G., Sherman B. T., Lane H. C. and Lempicki R. A. 2003 Identifying biological themes within list of genes with EASE. Genome Biol. 4, R70.
8. Huang L., Wei M. F. and Feng J. X. 2008 Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis. Eur. J. Pediatr. Surg. 18, 224–229.
9. Jiang T., Wang L., Li X., Song J., Wu X. and Zhou S. 2015 Inositol-requiring enzyme 1-mediated endoplasmic reticulum stress triggers apoptosis and fibrosis formation in liver cirrhosis rat models. Mol. Med. Rep. 11, 2941–2946.
10. Kiefer F. W., Zeyda M., Gollinger K., Pfau B., Neuhofer A., Weichhart T. et al. 2010 Neutralization of osteopontin inhibits obesity-induced inflammation and insulin resistance. Diabetes 59, 935–946.
11. Lai L., Yang X., Xu X., Jiang Y. and Tong M. 2005 Establishment of animal model with acute hepatic failure caused by lavage carbon tetrachloride. China J. Mod. Med. 15, 1155–1157.
12. Lee S. H., Seo G. S., Park Y. N., Yoo T. M. and Sohn D. H. 2004 Effects and regulation of osteopontin in rat hepatic stellate cells. Biochem. Pharmacol. 68, 2367–2378.
13. Lima-Cabello E., Garcia-Mediavilla M. V., Miquilena-Colina M. E., Vargas-Castrillon J., Lozano-Rodriguez T., Fernandez-Bermejo M. et al. 2011 Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C. Clin. Sci. (London) 120, 239–250.
14. Liu Y. F., Zha B. S., Zhang H. L., Zhu X. J., Li Y. H., Zhu J. et al. 2009 Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model. J. Exp. Clin. Cancer Res. 28, 107.
15. Lin Y. H. and Yang-Yen H. F. 2001 The osteopontin-CD44 survival signal involves activation of the phosphatidylinositol 3-kinase/Akt signaling pathway. J. Biol. Chem. 276, 46024–46030.
16. Nagoshi S. 2014 Osteopontin: versatile modulator of liver diseases. Hepatol. Res. 44, 22–30.
17. Otu H. H., Naxerova K., Ho K., Can H., Nesbitt N., Libermann T. A. et al. 2007 Restoration of liver mass after injury requires proliferative and not embryonic transcriptional patterns. J. Biol. Chem. 282, 11197–11204.
18. Phillips R. J., Helbig K. J., Van der Hoek K. H., Seth D. and Beard M. R. 2012 Osteopontin increases hepatocellular carcinoma cell growth in a CD44 dependant manner. World J. Gastroenterol. 18, 3389–3399.
19. Qin L. 2014 Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies. Front. Med. 8, 24–32.
20. Sahai A., Malladi P., Melin-Aldana H., Green R. M. and Whitington P. F. 2004 Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model. Am. J. Physiol. Gastrointest. Liver Physiol. 287, G264–G273.
21. Sodek J., Ganss B. and McKee M. D. 2000 Osteopontin. Crit. Rev. Oral Biol. Med. 11, 279–303.
22. Srungaram P., Rule J. A., Yuan H. J., Reimold A., Dahl B., Sanders C. et al. 2015 Plasma osteopontin in acute liver failure. Cytokine 73, 270–276.
23. Sun B. S., Dong Q. Z., Ye Q. H., Sun H. J., Jia H. L., Zhu X. Q. et al. 2008 Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma. Hepatology 48, 1834–1842.
24. Tajiri T., Tate G., Kunimura T., Endo Y., Inoue K., Mitsuya T. et al. 2005 Osteopontin expression in proliferated bile ductules: the correlation with liver damage in fulminant hepatitis. Dig. Dis. Sci. 50, 188–195.
25. Tiwari A., Shivananda S., Gopinath K. S. and Kumar A. 2014 MicroRNA-125a reduces proliferation and invasion of oral squamous cell carcinoma cells by targeting estrogen-related receptor alpha: implications for cancer therapeutics. J. Biol. Chem. 289, 32276–32290.
26. Urtasun R., Lopategi A., George J., Leung T. M., Lu Y., Wang X. et al. 2012 Osteopontin, an oxidant stress sensitive cytokine, up-regulates collagen-I via integrin alpha(V)beta(3) engagement and PI3K/pAkt/NFkappaB signaling. Hepatology 55, 594–608.
27. Wang G., Li X., Chen S., Zhao W., Yang J., Chang C. et al. 2015 Expression profiles uncover the correlation of OPN signaling pathways with rat liver regeneration at cellular level. Cell Biol. Int. 39, 1329–1340.
28. Wang G. P. and Xu C. S. 2010a Reference gene selection for real-time RT-PCR in eight kinds of rat regenerating hepatic cells. Mol. Biotechnol. 46, 49–57.
29. Wang G. P. and Xu C. S. 2010b Roles of osteopontin in liver development, regeneration and liver diseases. Chem. Life 30, 464–468.
30. Wang K. X. and Denhardt D. T. 2008 Osteopontin: role in immune regulation and stress responses. Cytokine Growth Factor Rev. 19, 333–345.
31. Wang X., Lopategi A., Ge X., Lu Y., Kitamura N., Urtasun R. et al. 2014 Osteopontin induces ductular reaction contributing to liver fibrosis. Gut 63, 1805–1818.
32. Wu X. L., Lin K. J., Bai A. P., Wang W. X., Meng X. K., Su X. L. et al. 2014 Osteopontin knockdown suppresses the growth and angiogenesis of colon cancer cells. World J. Gastroenterol. 20, 10440–10448.
33. Wu Y., Jiang W., Wang Y., Wu J., Saiyin H., Qiao X. et al. 2012 Breast cancer metastasis suppressor 1 regulates hepatocellular carcinoma cell apoptosis via suppressing osteopontin expression. PLoS One 7, e42976.
34. Xu C., Wang G., Hao Y., Zhi J., Zhang L. and Chang C. 2011a Correlation analysis between gene expression profile of rat liver tissues and high-fat emulsion-induced nonalcoholic fatty liver. Dig. Dis. Sci. 56, 2299–2308.
35. Xu C. S., Wang G. P., Zhang L. X., Chang C. F., Zhi J. and Hao Y. P. 2011b Correlation between liver cancer occurrence and gene expression profiles in rat liver tissue. Genet. Mol. Res. 10, 3480–3513.
36. Yang H., Guo H., Fan K., Zhang B., Zhao L., Hou S. et al. 2011 Clearance of propionibacterium acnes by kupffer cells is regulated by osteopontin through modulating the expression of p47phox. Mol. Immunol. 48, 2019–2026.
37. Zhao J., Dong L., Lu B., Wu G., Xu D., Chen J. et al. 2008 Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 135, 956–968.